TreeWAS – Variant ID: rs13029918

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J45.0 Predominantly allergic asthma	0.048	0.952	0.000
J45 Asthma	0.048	0.952	0.000
J45.9 Asthma, unspecified	0.047	0.953	0.000
J40-J47 Chronic lower respiratory diseases	0.042	0.958	0.000
J47 Bronchiectasis	0.040	0.960	0.000
J43 Emphysema	0.038	0.962	0.000
J45.8 Mixed asthma	0.035	0.965	0.000
J45.1 Nonallergic asthma	0.035	0.965	0.000
J43.9 Emphysema, unspecified	0.035	0.965	0.000
J40 Bronchitis, not specified as acute or chronic	0.033	0.967	0.000
J46 Status asthmaticus	0.032	0.968	0.000
J41 Simple and mucopurulent chronic bronchitis	0.030	0.970	0.000
J42 Unspecified chronic bronchitis	0.030	0.970	0.000
J43.8 Other emphysema	0.027	0.973	0.000
J43.2 Centrilobular emphysema	0.027	0.973	0.000
J43.1 Panlobular emphysema	0.027	0.973	0.000
J43.0 MacLeod's syndrome	0.027	0.973	0.000
J44 Other chronic obstructive pulmonary disease	0.022	0.978	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.022	0.978	0.000
J41.1 Mucopurulent chronic bronchitis	0.022	0.978	0.000
J41.0 Simple chronic bronchitis	0.022	0.978	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.018	0.982	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.016	0.984	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.015	0.984	0.000
L57.0 Actinic keratosis	0.007	0.993	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.007	0.993	0.000
J03.9 Acute tonsillitis, unspecified	0.007	0.993	0.000
N28.1 Cyst of kidney, acquired	0.006	0.994	0.000
R79.8 Other specified abnormal findings of blood chemistry	0.006	0.994	0.000
J03 Acute tonsillitis	0.005	0.995	0.000
I84.6 Residual haemorrhoidal skin tags	0.000	0.995	0.005
J00-J06 Acute upper respiratory infections	0.005	0.995	0.000
Chapter X Diseases of the respiratory system	0.004	0.996	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.004	0.996	0.000
J03.8 Acute tonsillitis due to other specified organisms	0.004	0.996	0.000
J03.0 Streptococcal tonsillitis	0.004	0.996	0.000
K42.9 Umbilical hernia without obstruction or gangrene	0.000	0.996	0.004
J00 Acute nasopharyngitis [common cold]	0.004	0.996	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.004	0.996	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.004	0.996	0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.004	0.996	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.004	0.996	0.000
J04 Acute laryngitis and tracheitis	0.003	0.996	0.000
J01 Acute sinusitis	0.003	0.996	0.000
Y40.0 Penicillins	0.004	0.996	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.003	0.997	0.000
R79 Other abnormal findings of blood chemistry	0.003	0.997	0.000
J85 Abscess of lung and mediastinum	0.003	0.997	0.000
Y83.2 Surgical operation with anastomosis, bypass or graft	0.000	0.997	0.003
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.003	0.997	0.000
L57.5 Actinic granuloma	0.003	0.997	0.000
L57.4 Cutis laxa senilis	0.003	0.997	0.000
L57.3 Poikiloderma of Civatte	0.003	0.997	0.000
L57.2 Cutis rhomboidalis nuchae	0.003	0.997	0.000
L57.1 Actinic reticuloid	0.003	0.997	0.000
J06 Acute upper respiratory infections of multiple and unspecified sites	0.003	0.997	0.000
J86 Pyothorax	0.003	0.997	0.000
T92.1 Sequelae of fracture of arm	0.003	0.997	0.000
J05.1 Acute epiglottitis	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
E27.2 Addisonian crisis	0.003	0.997	0.000
R56.8 Other and unspecified convulsions	0.000	0.997	0.003
J85.2 Abscess of lung without pneumonia	0.003	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
J60-J70 Lung diseases due to external agents	0.003	0.997	0.000
N28.0 Ischaemia and infarction of kidney	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
J05.0 Acute obstructive laryngitis [croup]	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
T92 Sequelae of injuries of upper limb	0.003	0.997	0.000
J04.2 Acute laryngotracheitis	0.003	0.997	0.000
J04.1 Acute tracheitis	0.003	0.997	0.000
J04.0 Acute laryngitis	0.003	0.997	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.003	0.997	0.000
E04.2 Non-toxic multinodular goitre	0.003	0.997	0.000
J01.8 Other acute sinusitis	0.003	0.997	0.000
J01.4 Acute pansinusitis	0.003	0.997	0.000
J01.3 Acute sphenoidal sinusitis	0.003	0.997	0.000
J01.2 Acute ethmoidal sinusitis	0.003	0.997	0.000
J01.1 Acute frontal sinusitis	0.003	0.997	0.000
J01.0 Acute maxillary sinusitis	0.003	0.997	0.000
Y95 Nosocomial condition	0.003	0.997	0.000
J01.9 Acute sinusitis, unspecified	0.003	0.997	0.000
J02 Acute pharyngitis	0.002	0.997	0.000
J86.9 Pyothorax without fistula	0.003	0.997	0.000
J95-J99 Other diseases of the respiratory system	0.003	0.997	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.003	0.997	0.000
J09-J18 Influenza and pneumonia	0.003	0.997	0.000
Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.000	0.997	0.003
J85.3 Abscess of mediastinum	0.002	0.997	0.000
J85.1 Abscess of lung with pneumonia	0.002	0.997	0.000
J85.0 Gangrene and necrosis of lung	0.002	0.997	0.000
Y83.6 Removal of other organ (partial) (total)	0.000	0.997	0.003
J90-J94 Other diseases of pleura	0.003	0.997	0.000
J06.8 Other acute upper respiratory infections of multiple sites	0.002	0.997	0.000
J06.0 Acute laryngopharyngitis	0.002	0.997	0.000
R79.0 Abnormal level of blood mineral	0.003	0.997	0.000
Y83.8 Other surgical procedures	0.000	0.997	0.003
J86.0 Pyothorax with fistula	0.002	0.997	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.003	0.997	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
J15 Bacterial pneumonia, not elsewhere classified	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
T92.0 Sequelae of open wound of upper limb	0.002	0.998	0.000
J70 Respiratory conditions due to other external agents	0.002	0.998	0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.002	0.998	0.000
J67 Hypersensitivity pneumonitis due to organic dust	0.002	0.998	0.000
J66 Airway disease due to specific organic dust	0.002	0.998	0.000
J63 Pneumoconiosis due to other inorganic dusts	0.002	0.998	0.000
J62 Pneumoconiosis due to dust containing silica	0.002	0.998	0.000
J65 Pneumoconiosis associated with tuberculosis	0.002	0.998	0.000
J64 Unspecified pneumoconiosis	0.002	0.998	0.000
J60 Coalworker's pneumoconiosis	0.002	0.998	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y83.3 Surgical operation with formation of external stoma	0.000	0.998	0.002
J14 Pneumonia due to Haemophilus influenzae	0.002	0.998	0.000
J93 Pneumothorax	0.002	0.998	0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.002	0.998	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.002	0.998	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.002	0.998	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.002	0.998	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Q61 Cystic kidney disease	0.002	0.998	0.000
J99 Respiratory disorders in diseases classified elsewhere	0.002	0.998	0.000
Y60.0 During surgical operation	0.002	0.998	0.000
J02.8 Acute pharyngitis due to other specified organisms	0.002	0.998	0.000
J02.0 Streptococcal pharyngitis	0.002	0.998	0.000
J06.9 Acute upper respiratory infection, unspecified	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
J93.1 Other spontaneous pneumothorax	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
J17 Pneumonia in diseases classified elsewhere	0.002	0.998	0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.002	0.998	0.000
J12 Viral pneumonia, not elsewhere classified	0.002	0.998	0.000
J11 Influenza, virus not identified	0.002	0.998	0.000
J09 Influenza due to certain identified influenza virus	0.002	0.998	0.000
J96 Respiratory failure, not elsewhere classified	0.002	0.998	0.000
Q60-Q64 Congenital malformations of the urinary system	0.002	0.998	0.000
J82 Pulmonary eosinophilia, not elsewhere classified	0.002	0.998	0.000
J80 Adult respiratory distress syndrome	0.002	0.998	0.000
J15.4 Pneumonia due to other streptococci	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
J10 Influenza due to identified influenza virus	0.002	0.998	0.000
J81 Pulmonary oedema	0.002	0.998	0.000
Q21.0 Ventricular septal defect	0.002	0.998	0.000
O03.9 Complete or unspecified, without complication	0.000	0.998	0.002
Q61.3 Polycystic kidney, unspecified	0.002	0.998	0.000
Y83.0 Surgical operation with transplant of whole organ	0.000	0.998	0.002
Q61.2 Polycystic kidney, adult type	0.002	0.998	0.000
Y83.4 Other reconstructive surgery	0.000	0.998	0.002
T93 Sequelae of injuries of lower limb	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
J15.9 Bacterial pneumonia, unspecified	0.002	0.998	0.000
J15.8 Other bacterial pneumonia	0.002	0.998	0.000
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.002	0.998	0.000
J15.5 Pneumonia due to Escherichia coli	0.002	0.998	0.000
J15.3 Pneumonia due to streptococcus, group B	0.002	0.998	0.000
J15.2 Pneumonia due to staphylococcus	0.002	0.998	0.000
J15.1 Pneumonia due to Pseudomonas	0.002	0.998	0.000
J15.0 Pneumonia due to Klebsiella pneumoniae	0.002	0.998	0.000
N28.8 Other specified disorders of kidney and ureter	0.002	0.998	0.000
Y83.5 Amputation of limb(s)	0.000	0.998	0.002
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
J69 Pneumonitis due to solids and liquids	0.002	0.998	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.002	0.998	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
J94 Other pleural conditions	0.002	0.998	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.002	0.998	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.002	0.998	0.000
J20-J22 Other acute lower respiratory infections	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
J92 Pleural plaque	0.002	0.998	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.002	0.998	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.002	0.998	0.000
J62.0 Pneumoconiosis due to talc dust	0.002	0.998	0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.002	0.998	0.000
J63.5 Stannosis	0.002	0.998	0.000
J63.4 Siderosis	0.002	0.998	0.000
J63.3 Graphite fibrosis (of lung)	0.002	0.998	0.000
J63.2 Berylliosis	0.002	0.998	0.000
J63.1 Bauxite fibrosis (of lung)	0.002	0.998	0.000
J63.0 Aluminosis (of lung)	0.002	0.998	0.000
J66.8 Airway disease due to other specific organic dusts	0.002	0.998	0.000
J66.2 Cannabinosis	0.002	0.998	0.000
J66.1 Flax-dresser's disease	0.002	0.998	0.000
J66.0 Byssinosis	0.002	0.998	0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.002	0.998	0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.002	0.998	0.000
J67.7 Air-conditioner and humidifier lung	0.002	0.998	0.000
J67.6 Maple-bark-stripper's lung	0.002	0.998	0.000
J67.5 Mushroom-worker's lung	0.002	0.998	0.000
J67.4 Maltworker's lung	0.002	0.998	0.000
J67.3 Suberosis	0.002	0.998	0.000
J67.2 Bird fancier's lung	0.002	0.998	0.000
J67.1 Bagassosis	0.002	0.998	0.000
J67.0 Farmer's lung	0.002	0.998	0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.002	0.998	0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.002	0.998	0.000
J70.9 Respiratory conditions due to unspecified external agent	0.002	0.998	0.000
J70.8 Respiratory conditions due to other specified external agents	0.002	0.998	0.000
J70.4 Drug-induced interstitial lung disorder, unspecified	0.002	0.998	0.000
J70.3 Chronic drug-induced interstitial lung disorders	0.002	0.998	0.000
J70.2 Acute drug-induced interstitial lung disorders	0.002	0.998	0.000
J70.1 Chronic and other pulmonary manifestations due to radiation	0.002	0.998	0.000
J70.0 Acute pulmonary manifestations due to radiation	0.002	0.998	0.000
Q61.0 Congenital single renal cyst	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
J93.8 Other pneumothorax	0.002	0.998	0.000
J93.0 Spontaneous tension pneumothorax	0.002	0.998	0.000
J99.8 Respiratory disorders in other diseases classified elsewhere	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Y83.9 Surgical procedure, unspecified	0.000	0.998	0.002
T90 Sequelae of injuries of head	0.002	0.998	0.000
Q61.9 Cystic kidney disease, unspecified	0.002	0.998	0.000
Q61.8 Other cystic kidney diseases	0.002	0.998	0.000
Q61.5 Medullary cystic kidney	0.002	0.998	0.000
Q61.4 Renal dysplasia	0.002	0.998	0.000
Q61.1 Polycystic kidney, infantile type	0.002	0.998	0.000
Q87.4 Marfan's syndrome	0.002	0.998	0.000
Q80-Q89 Other congenital malformations	0.002	0.998	0.000
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.002	0.998	0.000
J99.0 Rheumatoid lung disease	0.002	0.998	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.002	0.998	0.000
J93.9 Pneumothorax, unspecified	0.002	0.998	0.000
Q63.0 Accessory kidney	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.002	0.998	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.002	0.998	0.000
E23.0 Hypopituitarism	0.002	0.998	0.000
Q66.8 Other congenital deformities of feet	0.002	0.998	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
Q66 Congenital deformities of feet	0.002	0.998	0.000
Y91 Evidence of alcohol involvement determined by level of intoxication	0.002	0.998	0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level	0.002	0.998	0.000
Y98 Lifestyle-related condition	0.002	0.998	0.000
Y97 Environmental-pollution-related condition	0.002	0.998	0.000
Y96 Work-related condition	0.002	0.998	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.002	0.998	0.000
J11.8 Influenza with other manifestations, virus not identified	0.002	0.998	0.000
J11.1 Influenza with other respiratory manifestations, virus not identified	0.002	0.998	0.000
J11.0 Influenza with pneumonia, virus not identified	0.002	0.998	0.000
J12.9 Viral pneumonia, unspecified	0.002	0.998	0.000
J12.8 Other viral pneumonia	0.002	0.998	0.000
J12.3 Human metapneumovirus pneumonia	0.002	0.998	0.000
J12.2 Parainfluenza virus pneumonia	0.002	0.998	0.000
J12.1 Respiratory syncytial virus pneumonia	0.002	0.998	0.000
J12.0 Adenoviral pneumonia	0.002	0.998	0.000
J16.8 Pneumonia due to other specified infectious organisms	0.002	0.998	0.000
J16.0 Chlamydial pneumonia	0.002	0.998	0.000
J17.8 Pneumonia in other diseases classified elsewhere	0.002	0.998	0.000
J17.3 Pneumonia in parasitic diseases	0.002	0.998	0.000
J17.2 Pneumonia in mycoses	0.002	0.998	0.000
J17.1 Pneumonia in viral diseases classified elsewhere	0.002	0.998	0.000
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.002	0.998	0.000
J96.9 Respiratory failure, unspecified	0.002	0.998	0.000
J96.1 Chronic respiratory failure	0.002	0.998	0.000
J96.0 Acute respiratory failure	0.002	0.998	0.000
O03 Spontaneous abortion	0.000	0.998	0.002
Q64 Other congenital malformations of urinary system	0.002	0.998	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.002	0.998	0.000
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.000	0.998	0.001
J10.8 Influenza with other manifestations, influenza virus identified	0.002	0.998	0.000
J10.0 Influenza with pneumonia, influenza virus identified	0.002	0.998	0.000
R47.8 Other and unspecified speech disturbances	0.000	0.998	0.002
Q38-Q45 Other congenital malformations of the digestive system	0.002	0.998	0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.002	0.998	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.002	0.998	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.002	0.998	0.000
E23 Hypofunction and other disorders of pituitary gland	0.002	0.998	0.000
J91 Pleural effusion in conditions classified elsewhere	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
N92.6 Irregular menstruation, unspecified	0.000	0.998	0.002
Q21.9 Congenital malformation of cardiac septum, unspecified	0.002	0.998	0.000
Q21.8 Other congenital malformations of cardiac septa	0.002	0.998	0.000
Q21.4 Aortopulmonary septal defect	0.002	0.998	0.000
Q21.3 Tetralogy of Fallot	0.002	0.998	0.000
Q21.2 Atrioventricular septal defect	0.002	0.998	0.000
Q21.1 Atrial septal defect	0.002	0.998	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.002	0.998	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.002	0.998	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.002	0.998	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.002	0.998	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.002	0.998	0.000
T93.1 Sequelae of fracture of femur	0.002	0.998	0.000
T93.0 Sequelae of open wound of lower limb	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
J13 Pneumonia due to Streptococcus pneumoniae	0.002	0.998	0.000
I84.5 External haemorrhoids without complication	0.000	0.998	0.002
J69.8 Pneumonitis due to other solids and liquids	0.001	0.998	0.000
J69.1 Pneumonitis due to oils and essences	0.001	0.998	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.002	0.998	0.000
J95.5 Postprocedural subglottic stenosis	0.002	0.998	0.000
J95.4 Mendelson's syndrome	0.002	0.998	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.002	0.998	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.002	0.998	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.002	0.998	0.000
J95.0 Tracheostomy malfunction	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
T98 Sequelae of other and unspecified effects of external causes	0.002	0.998	0.000
T95 Sequelae of burns, corrosions and frostbite	0.002	0.998	0.000
T94 Sequelae of injuries involving multiple and unspecified body regions	0.002	0.998	0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.002	0.998	0.000
J94.9 Pleural condition, unspecified	0.002	0.998	0.000
J94.2 Haemothorax	0.002	0.998	0.000
J94.1 Fibrothorax	0.002	0.998	0.000
J94.0 Chylous effusion	0.002	0.998	0.000
T90.4 Sequelae of injury of eye and orbit	0.002	0.998	0.000
Y60.9 During unspecified surgical and medical care	0.002	0.998	0.000
Y60.8 During other surgical and medical care	0.002	0.998	0.000
Y60.7 During administration of enema	0.002	0.998	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.002	0.998	0.000
Y60.5 During heart catheterisation	0.002	0.998	0.000
Y60.4 During endoscopic examination	0.002	0.998	0.000
Y60.3 During injection or immunisation	0.002	0.998	0.000
Y60.2 During kidney dialysis or other perfusion	0.002	0.998	0.000
Y60.1 During infusion or transfusion	0.002	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
Q26 Congenital malformations of great veins	0.002	0.998	0.000
Q25 Congenital malformations of great arteries	0.002	0.998	0.000
Q24 Other congenital malformations of heart	0.002	0.998	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.002	0.998	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
Q43 Other congenital malformations of intestine	0.002	0.998	0.000
Q00-Q07 Congenital malformations of the nervous system	0.002	0.998	0.000
O03.4 Incomplete, without complication	0.000	0.998	0.002
Q63.9 Congenital malformation of kidney, unspecified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations